Re: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation
Agreement: I Agree Body: Dear Editor, Tang and colleagues present an intriguing analysis of non-scarring alopecia risk among patients initiated on GLP-1 receptor agonists (GLP-1RAs) [1]. However, the observed association